VistaGen Therapeutics Inc (VTGN) stock news · rev $1.3M
VistaGen Therapeutics Inc (VTGN) is a biotechnology company listed on NASDAQ.
This VTGN news page leads with what VistaGen Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for VTGN yet. We will not pad this page with generic market recap.
Latest reported VTGN revenue for 2026-03-31 was $1.3M. Net income was -$69.7M. Revenue was up 19.3% from 2024-03-31 to 2026-03-31. VTGN currently screens at market cap $28.1M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the VTGN stock page; for the tape open the quote page.
VTGN stock news FAQ
What are VTGN's latest revenue and net income?
Latest cached VistaGen Therapeutics Inc (VTGN) revenue for Mar 31, 2026 was $1.3M. Net income was -$69.7M. Statements: https://lician.com/financials/vtgn
How did VTGN revenue change from the prior cached period?
Cached VistaGen Therapeutics Inc (VTGN) revenue was up 19.3% from $1.1M (Mar 31, 2024) to $1.3M (Mar 31, 2026). Statements: https://lician.com/financials/vtgn
What is VTGN's market cap?
VistaGen Therapeutics Inc (VTGN) market cap is $28.1M on the latest cached fundamentals snapshot.
What kind of company is VTGN?
VistaGen Therapeutics Inc (VTGN) is a biotechnology company listed on NASDAQ.
Where is VTGN stock news listed?
Cached stock news for VistaGen Therapeutics Inc (VTGN) is listed at https://lician.com/news/vtgn. Filings: https://lician.com/sec/vtgn
Not investment advice.